Raphael Pharmaceutical Inc. (RAPH)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Operating Income | -$1.25M | -$1.51M | -$1.33M | -$3.32M | -$1.63M | -$706.0K |
| Net Income | -$1.28M | -$1.52M | -$1.34M | -$3.36M | -$1.62M | -$718.0K |
| EPS (Diluted) | $0.07 | $0.08 | $0.08 | $0.23 | $0.15 | — |
| Total Assets | $53.0K | $27.0K | $239.0K | $333.0K | $422.0K | $323.0K |
| Shareholders' Equity | -$1.43M | -$742.0K | $107.0K | $106.0K | $128.0K | -$43.0K |
| Cash & Equivalents | — | $19.0K | $230.0K | $288.0K | $153.0K | $95.0K |
| Operating Cash Flow | -$210.0K | -$532.0K | -$1.20M | -$759.0K | -$1.42M | -$779.0K |
| Capital Expenditures | — | — | — | $2.0K | — | — |
| Shares Outstanding | 20.18M | 18.70M | 18.50M | 15.62M | 12.97M | 9.46M |